Podcasts about molecular

What if the future of industry isn't giant factories, but molecular machines too small to see? DNA factories could repair bodies, grow habitats, and transform civilization.Get Nebula using my link for 50% off an annual subscription: https://go.nebula.tv/isaacarthurWatch my exclusive video Colonizing Ocean Worlds: https://nebula.tv/videos/isaacarthur-colonizing-ocean-worlds-subaquatic-settlementsCheck out Gods & Monsters: https://nebula.tv/curiousarchive/gods-and-monsters?ref=isaacarthur

What if the future of industry isn't giant factories, but molecular machines too small to see? DNA factories could repair bodies, grow habitats, and transform civilization.Get Nebula using my link for 50% off an annual subscription: https://go.nebula.tv/isaacarthurWatch my exclusive video Colonizing Ocean Worlds: https://nebula.tv/videos/isaacarthur-colonizing-ocean-worlds-subaquatic-settlementsCheck out Gods & Monsters: https://nebula.tv/curiousarchive/gods-and-monsters?ref=isaacarthur

Ross Halls is joined by Alex Jones for a Monday edition of Ipswich Town Transfer Talk.The boys reflect on a busy weekend of news, with deals agreed for Leicester City star Abdul Fatawu and Fulham defender Issa Diop.Then it's onto the Blues' interest in Dutch goalkeepers Kayne van Oevelen and Kjell Scherpen, playing at FC Volendam and Union SG respectively.There's also talk about Hidemasa Morita, the Japanese midfielder in talks over a switch to Portman Road after leaving Sporting CP.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Ex Ipswich Town chairman David Sheepshanks is feeling good about the future of his beloved Blues. Stuart Watson caught up with the former Town chief to discuss his new book, ‘Man on a Mission: The Agony and Ecstacy of a Life in Football'.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Beyond Traditional Medicine: The Science of Regeneration & Cellular Health with CEO Mick Emandi and Dr. Greg Carder Is regenerative medicine the future of healthcare—or one of the most misunderstood fields in modern medicine? In this thought-provoking episode of The Hurricane H Show, Hurricane H is joined by Mick Emandi, CEO of Regen MDs, and Dr. Greg Carder for an in-depth conversation exploring the rapidly evolving world of regenerative medicine, stem cell therapies, molecular hydrogen, and cellular health. Drawing from decades of healthcare leadership and clinical experience, Mick shares why he shifted his focus toward regenerative therapies after seeing countless patients exhaust traditional treatment options. Together with Dr. Carder, we examine the science behind stem cell technology, hydrogen inhalation therapy, inflammation, recovery, mitochondrial function, and the body's remarkable ability to heal. This balanced discussion separates science from hype, addresses common misconceptions, and explores how emerging evidence-based therapies may reshape the future of personalized healthcare, longevity, and wellness. Ultra RSF1 - Beyond Stem Cells & Exosomes - Ultra RSF-1 Regen MDs Care - Regen MDs THE EMBC NETWORK - YouTube THEEMBCNETWORKOFFICIAL - YouTube Topics Covered ✔️ Regenerative medicine explained ✔️ Stem cell therapy: Facts vs. myths ✔️ Molecular hydrogen & hydrogen inhalation therapy ✔️ Mitochondrial and cellular health ✔️ Chronic pain, inflammation & recovery ✔️ Evidence-based healthcare innovation ✔️ Patient-centered regenerative medicine ✔️ Longevity and the future of wellness An insightful conversation for anyone interested in the future of healthcare, performance, and living healthier through science-driven innovation.

Beyond Traditional Medicine: The Science of Regeneration & Cellular Health with CEO Mick Emandi and Dr. Greg Carder Is regenerative medicine the future of healthcare—or one of the most misunderstood fields in modern medicine? In this thought-provoking episode of The Hurricane H Show, Hurricane H is joined by Mick Emandi, CEO of Regen MDs, and Dr. Greg Carder for an in-depth conversation exploring the rapidly evolving world of regenerative medicine, stem cell therapies, molecular hydrogen, and cellular health. Drawing from decades of healthcare leadership and clinical experience, Mick shares why he shifted his focus toward regenerative therapies after seeing countless patients exhaust traditional treatment options. Together with Dr. Carder, we examine the science behind stem cell technology, hydrogen inhalation therapy, inflammation, recovery, mitochondrial function, and the body's remarkable ability to heal. This balanced discussion separates science from hype, addresses common misconceptions, and explores how emerging evidence-based therapies may reshape the future of personalized healthcare, longevity, and wellness. Ultra RSF1 - Beyond Stem Cells & Exosomes - Ultra RSF-1 Regen MDs Care - Regen MDs THE EMBC NETWORK - YouTube THEEMBCNETWORKOFFICIAL - YouTube Topics Covered ✔️ Regenerative medicine explained ✔️ Stem cell therapy: Facts vs. myths ✔️ Molecular hydrogen & hydrogen inhalation therapy ✔️ Mitochondrial and cellular health ✔️ Chronic pain, inflammation & recovery ✔️ Evidence-based healthcare innovation ✔️ Patient-centered regenerative medicine ✔️ Longevity and the future of wellness An insightful conversation for anyone interested in the future of healthcare, performance, and living healthier through science-driven innovation.

Beyond Traditional Medicine: The Science of Regeneration & Cellular Health with CEO Mick Emandi and Dr. Greg Carder Is regenerative medicine the future of healthcare—or one of the most misunderstood fields in modern medicine? In this thought-provoking episode of The Hurricane H Show, Hurricane H is joined by Mick Emandi, CEO of Regen MDs, and Dr. Greg Carder for an in-depth conversation exploring the rapidly evolving world of regenerative medicine, stem cell therapies, molecular hydrogen, and cellular health. Drawing from decades of healthcare leadership and clinical experience, Mick shares why he shifted his focus toward regenerative therapies after seeing countless patients exhaust traditional treatment options. Together with Dr. Carder, we examine the science behind stem cell technology, hydrogen inhalation therapy, inflammation, recovery, mitochondrial function, and the body's remarkable ability to heal. This balanced discussion separates science from hype, addresses common misconceptions, and explores how emerging evidence-based therapies may reshape the future of personalized healthcare, longevity, and wellness. Ultra RSF1 - Beyond Stem Cells & Exosomes - Ultra RSF-1 Regen MDs Care - Regen MDs THE EMBC NETWORK - YouTube THEEMBCNETWORKOFFICIAL - YouTube Topics Covered ✔️ Regenerative medicine explained ✔️ Stem cell therapy: Facts vs. myths ✔️ Molecular hydrogen & hydrogen inhalation therapy ✔️ Mitochondrial and cellular health ✔️ Chronic pain, inflammation & recovery ✔️ Evidence-based healthcare innovation ✔️ Patient-centered regenerative medicine ✔️ Longevity and the future of wellness An insightful conversation for anyone interested in the future of healthcare, performance, and living healthier through science-driven innovation.

Beyond Traditional Medicine: The Science of Regeneration & Cellular Health with CEO Mick Emandi and Dr. Greg Carder Is regenerative medicine the future of healthcare—or one of the most misunderstood fields in modern medicine? In this thought-provoking episode of The Hurricane H Show, Hurricane H is joined by Mick Emandi, CEO of Regen MDs, and Dr. Greg Carder for an in-depth conversation exploring the rapidly evolving world of regenerative medicine, stem cell therapies, molecular hydrogen, and cellular health. Drawing from decades of healthcare leadership and clinical experience, Mick shares why he shifted his focus toward regenerative therapies after seeing countless patients exhaust traditional treatment options. Together with Dr. Carder, we examine the science behind stem cell technology, hydrogen inhalation therapy, inflammation, recovery, mitochondrial function, and the body's remarkable ability to heal. This balanced discussion separates science from hype, addresses common misconceptions, and explores how emerging evidence-based therapies may reshape the future of personalized healthcare, longevity, and wellness. Ultra RSF1 - Beyond Stem Cells & Exosomes - Ultra RSF-1 Regen MDs Care - Regen MDs THE EMBC NETWORK - YouTube THEEMBCNETWORKOFFICIAL - YouTube Topics Covered ✔️ Regenerative medicine explained ✔️ Stem cell therapy: Facts vs. myths ✔️ Molecular hydrogen & hydrogen inhalation therapy ✔️ Mitochondrial and cellular health ✔️ Chronic pain, inflammation & recovery ✔️ Evidence-based healthcare innovation ✔️ Patient-centered regenerative medicine ✔️ Longevity and the future of wellness An insightful conversation for anyone interested in the future of healthcare, performance, and living healthier through science-driven innovation.

Mark Heath is joined by Stuart Watson and Alex Jones to discuss all things Ipswich Town on the latest KOA podcast.The boys start with very exciting news about our soon-to-be launched KOA app and website, before moving onto the latest sexy stuff.We discuss Town's interest in Abdul Fatawu, the noise around Jaden Philogene and a new link to a Dutch keeper. Then it's onto Mailbag, where we tackle questions ranging from our concern about Town's lack of signings so far to us fighting 10-year-olds.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Ross Halls is joined by Alex Jones for the latest episode of Ipswich Town Transfer Talk.The boys start by assessing some of the big-name links, including Patrick Berg, fresh off his World Cup display against England. Young Premier League duo Marc Guiu and Mikey Moore are said to be Town targets as well.Then it's on to some slightly different rumours, including Anthony Musaba and talks of a £10m bid, as well as Southampton's negotiations for ex-Blue Ivan Azon.There's also chat around Elkan Baggott, Cieran Slicker and Conor Chaplin, who have all been on the move in the last few days.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Encore registration - "Piano Ten Thousand Leaves" was completed on May 16, 2026. And as a post-completion activity, I hope to deliver it to people 1000 years from now. And so, I have begun "Piano Ten Thousand Leaves - beyond completion -- The Millennium Forest --". I will not be creating any new songs, but I will select one song from the 4536 songs I previously created and re-register it here. ===================================================== 《ピアノ万葉集》は2026年5月16日に完結しました。 そして完結後の活動として、1000年後の皆様に届けたいと考えています。 そして、《ピアノ万葉集》完結世界 -- 深森千年紀 -- を始めています。 そして新しい曲は創りませんが、前に創っている4536曲の中から１曲を選んでここで再登録させて頂きます。 =========================== The Complete Works of Piano Ten Thousand Leaves Vol.3-2 =========================== #spotify: https://open.spotify.com/intl-ja/album/3Vm796tVBoyWIEp1mLOpD6?si=XAl79oycSLew593UEF2VkQ #AppleMusic: https://music.apple.com/us/album/the-complete-works-of-piano-ten-thousand-leaves-vol-3-2/6787596397 #amazonmusic https://amazon.co.jp/music/player/albums/B0H7PGFDNP?marketplaceId=A1VC38T7YXB528&musicTerritory=JP&ref=dm_sh_TvnOaWB0wpvmYJqquVwEz0Do6 ＃YoutubeMusic: https://music.youtube.com/playlist?list=OLAK5uy_nwzdnA7O232R4vuv1c1duYeQAx9i9Rtak&si=5ojmgsW5cxlv0h_h #LineMusic https://lin.ee/5SED98v #AWA https://s.awa.fm/album/17c47b59557f20fb0620?t=1783245626 --- All Music Streaming Services: 全曲視聴可能なのが嬉しいですね… https://linkco.re/rqBErhU1 =========================== The Complete Works of Piano Ten Thousand Leaves Vol.3-1 =========================== VOLUME3-1 just released! Gentleness, carried on 4,536 leaves of sound. #spotify: https://open.spotify.com/intl-ja/album/5aSDLOUFLgmoK0Nu5uYvxK?si=FxFC1shbTNmcVsbGuZzufw #AppleMusic:  #amazonmusic https://amazon.co.jp/music/player/albums/B0H6VDD1KC?marketplaceId=A1VC38T7YXB528&musicTerritory=JP&ref=dm_sh_Ke44Vvf27v9Scn17Q3GlghCkH ＃YoutubeMusic: https://music.youtube.com/playlist?list=OLAK5uy_keXkSwBS2JvaxE-tEwAuXmIOe4CzSijgY&si=tJYfAwa-8cQ8sUyh #LineMusic https://lin.ee/pOzyULD #AWA https://s.awa.fm/album/95f94c20e913e538ed09?t=1782684025 --- All Music Streaming Services: 全曲視聴可能なのが嬉しいですね… https://linkco.re/AAZ0NrcQ

Molecular farming has the potential to add a new layer of value to existing operations without requiring major operational changes.

Ross Halls caught up with former Ipswich Town forward Paul Goddard to discuss his time at Portman Road and journey in football for the latest of our Kings of Anglia podcast specials.Paul spoke about a range of memories, including getting into football, playing for the likes of QPR, West Ham, Newcastle Derby County and Millwall.Then it's onto his spell at Town from relationship with John Lyall, his Sarge nickname, winning the Second Division title, playing in the Premier League, being joint-caretaker manager with John Wark and becoming a coach.The duo also discuss life in Suffolk, being an football agent and what the future holds.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Featuring perspectives from Dr Floor J Backes, Dr Matthew A Powell and Dr Ritu Salani, moderated by Dr Salani, including the following topics: Case: A woman in her late 70s with de novo metastatic mismatch repair-proficient metastatic endometrioid endometrial cancer (00:00) Molecular analyses in the assessment and management of endometrial cancer (07:33) CME information and select publications

Ross Halls is joined by Stuart Watson for the latest episode of Ipswich Town transfer talk.The boys start by discussing Hearts striker Cláudio Braga, whom Town have reportedly 'entered the race' to sign and a new goalkeeper link in Kjell Scherpen.Then it's onto some other interesting names, with the Blues said to be rivalling Hull City for Lazio left-back Luca Pellegrini, while Simon Adingra has also been linked.There's also chat around Jaden Philogene switching his agency and if that means he could leave Portman Road this summer.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Some of the world's most popular natural flavors come from plants that are difficult to grow or may only produce small amounts of the compounds we use.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TPJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 29, 2027.Therapeutic Progress and IMPACT in CRC: Expert Guidance on Applying Rapidly Emerging Evidence on Immunotherapy and Molecular, Precision-Based Approaches in CRC Treatment In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported through medical education grants from Bristol Myers Squibb, Exelixis, Inc., Johnson & Johnson, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TPJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 29, 2027.Therapeutic Progress and IMPACT in CRC: Expert Guidance on Applying Rapidly Emerging Evidence on Immunotherapy and Molecular, Precision-Based Approaches in CRC Treatment In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported through medical education grants from Bristol Myers Squibb, Exelixis, Inc., Johnson & Johnson, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TPJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 29, 2027.Therapeutic Progress and IMPACT in CRC: Expert Guidance on Applying Rapidly Emerging Evidence on Immunotherapy and Molecular, Precision-Based Approaches in CRC Treatment In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported through medical education grants from Bristol Myers Squibb, Exelixis, Inc., Johnson & Johnson, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.

Molecular biology is more than a set of techniques. It is a toolkit for asking better questions. In this special crossover episode of Speaking of Mol Bio, Steve Lewis welcomes Jordan Ruggieri, Senior Marketing Manager at Thermo Fisher Scientific and co-host of the Absolute Gene-ius podcast. Jordan shares how Absolute Gene-ius began with a focus on digital PCR and evolved into a broader celebration of molecular genetics, genomics, and the scientists using diverse tools across multiple research areas. From endpoint PCR and qPCR to digital PCR, sequencing, sample prep, and downstream analysis, the conversation highlights how different technologies work together to help researchers move from sample to answer. Jordan also reflects on memorable podcast stories, including Antarctic microbial research, transplant science, lab mishaps, and the ways PCR-enabled discoveries can have real-world human impact. The episode also explores themes that run through many scientific careers: curiosity, grit, mentorship, failure, and openness to unexpected opportunities. Jordan shares his own path from aspiring dentist to R&D scientist, marketer, and podcast host, while offering early-career scientists practical advice: stay open, keep learning, and make time for hobbies and life outside the lab. Subscribe to get future episodes as they drop and if you like what you're hearing we hope you'll share a review or recommend the series to a colleague.  Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology. For Research Use Only. Not for use in diagnostic procedures.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TPJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 29, 2027.Therapeutic Progress and IMPACT in CRC: Expert Guidance on Applying Rapidly Emerging Evidence on Immunotherapy and Molecular, Precision-Based Approaches in CRC Treatment In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported through medical education grants from Bristol Myers Squibb, Exelixis, Inc., Johnson & Johnson, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.

Mark Heath is joined by Stuart Watson and Ross Halls to discuss all things Ipswich Town as business picks up at the Blues.We start with the impending arrival of Brazilian striker Emersonn, who looks set to sign in a club record deal.Then it's onto the return of Wes Burns and the impact he can have in the Premier League, before we chat about the new home and away kits which were released last week.We finish with the departure of Martyn Pert and many of McKenna's backroom staff, plus the start of pre-season.And we have news of a big KOA milestone!Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Ross Halls caught up with former Ipswich Town forward Jack Lankester to discuss his time at Portman Road and journey in football for the latest of our Kings of Anglia podcast specials.Jack spoke about a range of memories, including getting into football, joining Town's academy aged seven, being a fan and progressing through the youth ranks. He chats about which senior players helped him, making his debut under Paul Hurst, relationship with Paul Lambert, goal against Millwall and long term back injury.The duo also discuss his return to action, being sold by Paul Cook, career since he departed Town and what the future holds.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Ross Halls is joined by Alex Jones for the latest episode of Ipswich Town Transfer Talk.The boys start by discussing veteran striker Callum Wilson and Juventus defender Lloyd Kelly, both named in Stuart Watson's exclusive story from last week.Then it's onto some other interesting names, with the Blues said to be rivalling Hull City for Brazilians Alexsandro and Emersonn, with Guillaume Restes also linked.There's also chat around Torino's Cesare Casadei, ex-Wolves skipper Max Kilman, and Southampton wide man Tom Fellows.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Ross Halls is joined by Alex Jones for the latest edition of the Kings of Anglia Ipswich Town podcast.The boys share their thoughts on the new kits for the 2026/27 Premier League season.Plus take questions and thoughts from fans watching live.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

ReferencesNeuroendocrinology. 2000 Mar;71(3):187-95J Immunol.2014 Jan 3;192(3):979–984.Molecular and Cellular Endocrinology 2018.Volume 472, 5 September: 40-49Front. Immunol., 2023. 16 March Sec. T Cell Biology.Volume 14 -Guerra, DJ. 2026. Unpublished Lectures.Emerson/Lake/Palmer. 1972. Trilogy lp. fullhttps://music.youtube.com/playlist?list=OLAK5uy_m-KrYKLiBdrOau11bsTte7M4qSR0en7VI&si=DwpdwN0nR_IGNsK1

This episode has a fun personal twist: There's a counterfactual world where I was employee #1 at Genesis Molecular AI, the company behind today's episode. A certain introduction happened a few weeks too late and I had already happily signed at Atomwise, another ML-for-drug-discovery startup. Same problem, different company. I was certain ML was going to transform small molecule drug discovery. Early results were underwhelming. Useful at times, but nowhere near revolutionary. In the last year I've seen signs that ML is finally ready to deliver on my convictions from a decade ago. Genesis is one of the places that might have finally cracked this problem. I was super excited to come full circle and catch up with co-founder Evan Feinberg and CTO Sergey Edunov.If you are at all interested in small molecule drug discovery, we think you will find this fascinating!In our nearly two hour chat we cover:* What is small molecule drug discovery, and why is it hard* Structure prediction as a hotbed of innovation in AI algorithms* How advances in AI elsewhere have enabled stepwise improvements in predictive power* How the community benchmarks are essentially calling AI slop good enough* The Genesis flagship model (PEARL) can routinely hit a threshold that is necessary for real-world applications* New agentic workflows enabled by these highly accurate modelsRead on for more, and also some personal thoughts on the future at the end.The coolest diffusion research is happening at GenesisSergey Edunov came to Genesis from Meta where he led Llama 2 training and Llama 3 pretraining. Sergey was a former physicist who thought he was done with physics after many years of training LLMs. Then, he discovered Genesis, and was blown away with all the novel architecture work they've been developing.It probably surprises no one that modern LLM research has not resulted in fundamentally novel or exciting updates in architectures since almost the advent of the transformer — the entire field is using variants on the same idea that came out in the original “Attention is all you need” paper. Sure, some were quite useful (mixture-of-experts in particular allowed for the massive model paradigm we're at today), but there was very little conceptually exciting.“We sort of had to wait for the right primitive to get created, and that turned out to be diffusion… Actually, some of the most innovative diffusion research that's happening in our field is happening in 3D structure prediction right now.” — Evan FeinbergThe field of 3D structure prediction on the other hand has been a hotbed of research. Genesis' recent model PEARL (Place Every Atom at the Right Location) is able to understand protein flexibility, and model not just where the ligand goes, but also make small adjustments of the protein so that the two fit better than either alone. The field knew this was missing for a long time, but it was really hard to model until now.Agentic DiscoveryWhat makes this problem so hard? As Sergey points out, there are 10^60 possible drug-like small molecules. You'll never be able to search them all, and trying to find the good ones is something like finding a needle in a haystack — except everything except your needle is dangerous.“There are 10 to the 60 drug-like small molecules in the universe… it's like finding a needle in a haystack, where everything except your needle is very, very dangerous.” — Sergey Edunov“Or finding hay in a needle stack might be a more apt analogy.” — Evan FeinbergTrying to solve the multi-parameter optimization problem is even worse. What makes a strong binder and a molecule with good “ADMET Properties” are oftentimes at tension with each other. For example, a good binder is likely greasy, but a greasy molecule is likely insoluble so it won't enter the bloodstream and get to where it needs to go!Genesis' advances in generative AI have now pushed them beyond the threshold where they believe agentic drug discovery loops are finally possible. We all remember the early days of LLMs. They were great chatbots but terrible agents, as small errors compounded rapidly into uselessness. As LLMs got better, the usefulness of agents rapidly improved. Evan and Sergey argue that their models at Genesis recently passed a similar threshold. Their internal agentic drug-discovery system (code named SAPPHIRE) can now iterate like a chemist: look at and reason about poses, form hypotheses, read literature, use internal tools, create candidates for the next iteration. Combining this with automated lab partnerships like the one Genesis has with Incyte, we're rapidly approaching a time of drug discovery agents running 24/7 making/testing new molecules. Exciting times!Benchmark crisis: Everyone's favorite benchmark is slopOne surprising point that isn't talked enough about: the academic field of “co-folding” has settled on a benchmark value of “2 Angstrom RMSD” as a metric for a “good pose”. Evan does not mince words: this threshold is just bad. Perhaps even deceptively bad. For many strong binders, there's a very clear pose, one that you can even directly resolve in the PDB electron density! And yet, with a 2Å RMSD threshold, you can get the pose quite wrong in ways that might even mislead a medicinal chemist. For example, flip around an aromatic ring, and everything looks reasonable, but you're no longer modeling the right interactions.Evan makes the strong claim that 1Å RMSD is really the threshold necessary to ensure the core of the molecule is sitting where it needs to be, and models all interactions.“If your model is sitting at 1.8, 1.9 Angstrom RMSD, that's slop, most likely.” — Evan FeinbergAs a simple example, he points out hydrogen bonds which are responsible for many of the most important interactions in protein-ligand systems. Hydrogen bonds only have a 0.6Å range to be valid! Clearly if you're accurately resolving all H-bonds, you generally have to be doing much better than the 2Å threshold.This is clearly a hard-fought lesson for Evan and Genesis. In their opinion, the community is stuck on these benchmarks because academics developing methods were not users. Evan does see signs of life, with the use of new metrics such as lDDT for co-folding. Hopefully soon the community can agree that “1.8Å RMSD is slop”, and start hill climbing on this much harder task.For a more thorough exploration of the weaknesses in conventional benchmarks, see the PEARL technical report.PEARL tops OpenBindWhich makes what happened next all the more striking. Near the end of the podcast, we talked about a recent “proof-is-in-the-pudding” moment for Genesis — evaluating their PEARL model on a recently released OpenBind benchmark. This benchmark featured 802 never before seen co-complexes on a target protein EV-A71. This target seems almost custom-chosen to give most classical docking methods a problem. When a ligand binds to the main binding site, the protein moves around to close off the path the ligand used to enter the binding pocket. This process, known as “induced fit” is notoriously hard for traditional methods to model. The tradeoff is easy to understand: treating the protein as a static structure, it becomes difficult to place a ligand in a binding pocket. Treat the protein as dynamic, and now you have to simulate complicated processes that take a long time to resolve.PEARL was able to model the induced fit of the ligand without running long MD simulations. Across the different evaluation metrics, PEARL came out not just ahead, but oftentimes well ahead of any public model. A truly impressive result.“Where PEARL was exceptionally good is figuring out how to move this loop. We are basically correct for every single pose.” — Sergey EdunovEven more exciting, this was done without any fine-tuning, or using any data on the target or homologous targets — the template PDB was released after PEARL's training cutoff.Where does co-folding go now?As someone who has followed or participated in ML techniques for protein-ligand interactions for almost a decade, I was genuinely impressed with the results that Genesis has released recently. This has been many years in development, and I'm sure Evan and the team had many sleepless nights trying to get to this point. I also think other teams are making similar progress — both Isomorphic and Deep Origin have released results that seem spiritually similar and combine computation, wetlab data, ML, to achieve genuine predictive power that seemed impossible a decade ago. Sadly, all of the above are closed source so there's no way to honestly compare them. Looking at the results I think there might be a time in the not so distant future where we can consider protein-ligand binding “solved”.I sincerely hope that the academic community can take inspiration from these developments. Once you know something can be done, it's much easier to execute. Still, I believe that the key enabler in all of the above was the tight integration of ML, large-scale computation, and real-world drug discovery applications. Sadly academia is just not structured in a way that makes such a development easy.With those parting thoughts, we hope you give the podcast a listen! This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.latent.space/subscribe

Ross Halls is joined by Stuart Watson and Alex Jones for the latest edition of the Kings of Anglia Ipswich Town podcast.The boys complete the great squad audit of 2026, looking at every player who could be involved for the Blues in the Premier League next season.There are decisions to be made. Who stays in the squad, who gets a loan move, and who will move on permanently this summer? There's plenty of debate as we go through every position.There's also a look at who will fit Gary O'Neil's style of play and how many new signings will be needed as Town prepare to tackle the top flight.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

A enthusiastic Australian jogger who collected whale poo on his runs and stashed it in the freezer has provided scientists with a veritable treasure trove. The dung and whale poo from other areas has revealed valuable new information about the diet and gut health of the Southern right whale or tohora. Molecular ecologist Associate Professor Emma Carroll from Auckland University who's made a career out of studying dolphins and whales spoke to Lisa Owen.

Ross Halls caught up with former Ipswich Town loanee Jonny Williams to discuss his time at Portman Road and journey in football in our Kings of Anglia podcast special.Jonny spoke about a range of memories, including his early days in football, starting out at Crystal Palace, breaking into the first-team, winning promotion and joining Town on loan.He chats about his relationship with Mick McCarthy, key memories, injury set-backs, potential of a permanent move, 'Joniesta nickname' and overall time in Suffolk.The duo also discuss playing for Wales at major tournaments, being a free agent and what the future holds.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Ross Halls is joined by Alex Jones for the latest edition of Ipswich Town transfer talk.The boys sit down to discuss the first links of the Gary O'Neil era, including strikers Lucas Stassin and Daniel Jebbison.Then it's onto the goalkeepers, with more on Viktor Johansson, Nick Pope and Radek Vitek.There's also chat around potential departures, including Wes Burns, Harry Clarke and Jaden Philogene.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Elo Life Systems: https://elolife.com/Super excited to bring on Matt DiLeo of ELO Life Systems on today's episode. Some of you may remember that ELO Life CEO Todd Rands was a part of 412 of this podcast two years ago. I've been fascinated by their work ever since to bring to the market what they call molecular farming. Matt does a great job of explaining the concept and how this shifts the value in some ways from food processors back to the farm by allowing farmers to grow desirable healthy ingredients inside of the commodity crops they already grow. It's kinda mind blowing. Some background on Matt: Dr. Matt DiLeo serves as the vice president of research & development at Elo Life Systems. In his role, Matt applies agricultural OMICs and precision breeding technologies to advance Elo's product pipeline. Prior to joining Elo, Matt held scientific leadership roles at Novozymes and KeyGene USA. Matt received his Ph.D. in Plant Pathology from UC Davis and completed a postdoc at the Boyce Thompson Institute, where he studied the impact of silencing regulatory genes on the nutritional composition of the tomato fruit metabolome.Matt seems to have a knack for being on the cutting edge of ag science and technology and has shown this in a variety of areas throughout his career.

LeAnn is a phytoplankton molecular ecologist, or, according to her daughter, a phytoplankton nerd. LeAnn grew up in Machias, and thanks to her participation in the Keller BLOOM Program at Bigelow Laboratory for Ocean Sciences as a junior in high school, she found her love for plankton and studying the ocean for a living. After receiving her Ph.D. in Cell and Molecular Biology from the University of Rhode Island in 2012, LeAnn returned to Maine - first as a postdoctoral researcher at Bigelow  and in 2018, joining the faculty at Maine Maritime Academy. LeAnn was one of this year's 5 Minute Genius speakers at the 2026 Maine Science Festival. Some definitions of the terms used during our conversation: eukaryotic - organisms whose cells have a membrane-bound nucleus. prokaryotic cells - organisms that  do not have a membrane-bound nucleus phytoplankton - mostly microscopic, single-celled photosynthetic organisms that live suspended in water. They form the base of the food chain and like all plants, take up carbon dioxide, make carbohydrates using light energy, and release oxygen. Additional information can be found at https://www.whoi.edu/ocean-learning-hub/ocean-topics/ocean-life/ocean-plants/phytoplankton/ and https://science.nasa.gov/earth/earth-observatory/what-are-phytoplankton/. diatoms & dinoflagellates - types of phytoplankton This conversation was recorded in May 2026. ~~~~~The Maine Science Podcast is a production of the Maine Discovery Museum. It is recorded at Discovery Studios, at the Maine Discovery Museum, in Bangor, ME. The Maine Science Podcast is hosted and executive produced by Kate Dickerson; edited and produced by Scott Loiselle. The Discover Maine theme was composed and performed by Nick Parker. To support our work: https://www.mainediscoverymuseum.org/donate. Find us online:Maine Discovery MuseumMaine Discovery Museum on social media: Facebook Instagram LinkedIn Bluesky YouTubeMaine Science Podcast on social media: Facebook Instagram YouTubeMaine Science Festival on social media: Facebook Instagram LinkedIn YouTube© 2026 Maine Discovery Museum

Ross Halls is joined by Alex Jones for a live podcast to discuss Ipswich Town's appointment of new boss Gary O'Neil.The boys start by discussing his arrival before analysing his first press conference, setting out his plans for the club and discussing his past experience in England and abroad.Then it's onto his backroom staff. Who else arrives at Portman Road, and who moves on? There's a conversation about potential targets and tactics to expect, too.There's also chat around pre-season and the Blues' Under-21s entering the EFL Trophy, while Ross and AJ take questions from fans watching live.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Ross Halls is joined by Stuart Watson and Alex Jones to discuss Ipswich Town's search for a new manager.The boys discuss Gary O'Neil, who is set to be named the next Blues' boss following Kieran McKenna's departure.There's chat about his expected appointment, including his tactics, fan reaction, and his first tasks to tackle in the role.Then Stu gets his chance to discuss the 2026/27 Premier League fixtures, including August's opener at home to Sunderland and the run-in.There's also chat about the summer heatwave, while AJ discusses his experience watching Gorillaz over the weekend.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Bosma arhinia microphthalmia syndrome (BAMS) is a rare genetic disorder resulting in babies born without a nose, along with eye and reproductive anomalies. Our guests today investigated the developmental basis of this distinct defect using induced pluripotent stem cells (iPSCs) derived from patients with BAMS. They assessed the differentiation potential of BAMS patient-derived iPSCs into cranial placode cells, a group of progenitor cells that contribute to the formation of the nasal epithelium. This allowed them to study the behavior of the nasal epithelial cells during early development. Their work uncovered cellular mechanisms underlying BAMS and provided new insights into the developmental processes that shape the human nose. GuestsShifeng Xue is an Assistant Professor in the Department of Biological Sciences at the National University of Singapore (NUS). She received her Ph.D. in developmental biology from the University of California, San Francisco, where she trained with Maria Barna, and then completed her postdoctoral research at the Institute of Molecular and Cell Biology, A*STAR, Singapore. She is the recipient of the 2018 Young Scientist Award of the Singapore National Academy of Science.  Vanitha Venkoba Rao worked as a Research Fellow at NUS from 2020 to 2025. She earned her Ph.D. in Biochemistry and Molecular Biology from NUS and subsequently held research positions at inStem and Pandorum Technologies in India, before joining the Xue lab.HostJanet Rossant, Editor-in-Chief, Stem Cell Reports Supporting DocumentCranial placode differentiation defect in individuals born without a nose, Stem Cell Reports, 2026About Stem Cell ReportsStem Cell Reports is the open access, peer-reviewed journal of the International Society for Stem Cell Research (ISSCR) for communicating basic discoveries in stem cell research, in addition to translational and clinical studies. Stem Cell Reports focuses on original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians. X: @StemCellReportsAbout ISSCRAcross more than 80 countries, the International Society for Stem Cell Research (@ISSCR) is the preeminent global, cross-disciplinary, science-based organization dedicated to advancing stem cell research and its translation to medicine.ISSCR StaffKeith Alm, Shuangshuang Du, Kym Kilbourne, Megan Koch, Jack Mosher, and Hunter Reed

Ross Halls caught up with former Ipswich Town forward David Lowe to discuss his time at Portman Road and journey in football in our Kings of Anglia podcast special.David spoke about a range of memories, including his early days in football, making his name at Wigan Athletic, scoring at Wembley and joining Ipswich.He chats about his relationship with John Duncan, debut season, trademark shuffle, favourite strike partners, ACL injury and overall time in Suffolk.The duo also discuss his journey in coaching, his spell as caretaker manager at Blackburn Rovers and what the future holds.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Ross Halls is joined by Alex Jones for the latest Kings of Anglia Ipswich Town podcast.The boys break down the 2026/27 Premier League fixtures, with Town kicking off the campaign at home to Sunderland before travelling to Man United.When are the key games? Are there any tough runs or unique quirks to look out for? Ross and AJ share their thoughts on what's to come, with the Blues aiming to survive in the top flight.Then it's onto pre-season, the plans in place and the friendlies scheduled for July and August as the players return to match action.There's also chat around the manager search, with Gary O'Neil and Ole Gunnar Solskjaer in the race to take over from Kieran McKenna.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Molecular hydrogen improves your body's antioxidant defenses instead of directly lowering oxidative stress, helping you recover without blocking muscle adaptation Molecular hydrogen helps you maintain speed and power during repeated sprints, especially in the final, fatigue-heavy stages where performance normally declines Hydrogen supports your cellular energy systems by improving mitochondrial function, allowing your muscles to maintain power under stress Unlike traditional antioxidants, hydrogen targets only the most damaging molecules, preserving the signals your body relies on to build strength and endurance Using hydrogen in short, repeated doses, especially through hydrogen-rich water, strengthens your body's resilience and speeds recovery over time

Ross Halls is joined by Alex Jones for the latest episode of Ipswich Town Transfer Talk.The boys start with the latest news on the Blues' manager search, with what looks to be like a two-horse race to replace Kieran McKenna at Portman Road.There's talk about the best fit, with possible pros and cons, before moving onto the latest transfer links.That includes a highly-rated La Liga striker and a newly-capped Italian no.9, plus chat around Nick Pope and a potential move for another shot-stopper.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Alex Jones is joined by football finance expert Kieran Maguire for another KOA exclusive interview following Ipswich Town's return to the Premier League.There's talk around the true value of promotion in 2026 before addressing the elephant in the room - the new financial rules that will impact the Blues and their top-flight foes.Then it's onto the summer transfer window. How much will Town look to spend, and just how important will foreign recruitment me?There's also chat about the importance of survival as Ipswich aim to establish themselves in the top flight.NOTE: This podcast was recorded before Kieran McKenna's departure was confirmed.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Welcome back to the Jack Westin MCAT Podcast with Mike and Molly! Last episode we tackled gels, SDS-PAGE and Western blots. Now we move into one of the most high-yield experimental technique topics on the MCAT: chromatography.If you have ever seen a chromatography question in a passage and had no idea where to start, this episode gives you a framework that works for every single type. No memorizing, just understanding.Get started with our resources!

In this solo episode, David Brühlmann explores the evolving landscape of biologic manufacturing platforms beyond CHO (Chinese hamster ovary) cells. Drawing from previous interviews with platform pioneers and rigorous data analysis, David examines where established and emerging hosts find their strengths—and their limits—in today's biomanufacturing environment.Topics DiscussedThe historical dominance of CHO cells and what's changed in the last decade (00:08)Three critical areas where alternative hosts might outperform CHO: cost, speed, and intrinsic product quality (04:52)Moss as a production platform: regulatory advantages, glycosylation, and oncology antibodies (05:47)Microalgae's carbon-negative potential and the current 1000-fold yield challenge (08:28)Molecular farming (plant-based production): timelines, case of the Medicago COVID-19 vaccine, and overcoming political—not technical—barriers (10:41)Silkworm-based production: infrastructure cost, individual variability, and progress in vaccines (13:07)Cyanobacteria: promise of photosynthetic biomanufacturing and current limitations for clinical use (15:06)The pattern emerging among all alternative platforms: finding niche advantages rather than universally replacing CHO (18:25)A framework for evaluating novel hosts moving forward (19:14)Part 2 examines whether “Will it replace CHO?” is the right question to be asking at all, and introduces an alternative framework for evaluating the issue more effectively.Smart insight:None of the “novel hosts” are universal CHO replacements. Winners emerge in narrow niches: plant farming for pandemic-scale vaccines, silkworms in veterinary and oral applications, and cyanobacteria as a long-term bet for sustainable production.Here are the episodes referenced:Episodes 163 - 164: How Moss Enables Production of Unproducible Protein Therapeutics with Andreas SchaafEpisodes 141 - 142: How Microalgae Cuts Antibody Costs by 70% and Redefines Biomanufacturing with Muriel BardorEpisodes 235 - 236: Plant-Based Biomanufacturing: How Molecular Farming Produces Biopharmaceuticals in Weeks, Not Months with Waranyoo PhoolcharoenEpisodes 217 - 218: Silkworm Biomanufacturing: From Ancient Silk Production to Phase I Vaccine Trials with Masafumi OsawaEpisodes 229 - 230: Cyanobacteria Biomanufacturing: Achieving Carbon-Neutral Production at Lower Cost Than Fermentation with Tim CorcoranNext:If you enjoyed this episode, please leave a review on Apple Podcasts or your favorite podcast platform. By doing so, we can empower more scientists like you. Stay tuned for more inspiring biotech insights in our next episode.Support the show

Dr. Michael Park shares stories from a Proof-of-Concept study that combined lumbar or lumbosacral decompression and fusion surgery and neuromodulation. Dr. Park is a former principal investigator of the SynerFuse® proof-of-concept clinical trial and primary inventor of SynerFuse® technology. Dr. Park is a board-certified neurosurgeon, an associate professor, MnDRIVE neuromodulation scholar, William P. Van Wagenen Fellow, and director of stereotactic and functional neurosurgery in the Department of Neurosurgery and Neurology at the University of Minnesota. He has extensive experience with neuromodulation – deep brain stimulation. This surgical therapy for brain conditions such as Parkinson's disease, essential tremor, and dystonia modulates brain activity to treat symptoms. He also uses neuromodulation such as spinal cord stimulation and intrathecal drug delivery to treat cancer pain and chronic pain. In addition, working with epilepsy specialists, Dr. Park performs procedures such as surgical placement of depth and grid electrodes in the brain to identify abnormal epileptic brain areas and offer treatments which include resection, response neural stimulator (NeuroPace) placement, laser ablation, and vagal nerve stimulation. If patients are unable to have surgery, Dr. Park is able to treat some of the conditions using Gamma Knife radiosurgery as well. Dr. Park received his dual Bachelor of Arts and Sciences in economics and electrical engineering from Cornell University and a Bachelor of Arts in biology from the University of Kansas. He holds an M.D. and Ph.D. from the School of Medicine and Graduate Studies, Department of Molecular and Integrative Physiology, at the University of Kansas. He completed his neurosurgery residency at the Rhode Island Hospital/Brown University. He was awarded the prestigious William P. Van Wagenen Fellowship from the American Association of Neurological Surgeons and completed his fellowship with Dr. Jean Régis at the Université de la Méditerranée Aix-Marseille II, Assistance Publique L'Hôpital d'Adulte de la Timone in Marseille, France, in 2010. He was an Assistant Professor and the Director of Functional Neurosurgery and Pain in the Department of Neurosurgery at University of Louisville until 2014. Resources: Integrating Dorsal Root Ganglion Stimulation with Transforaminal Lumbar Interbody Fusion: Proof of Concept Study SynerFuse University of Minnesota Sponsor The Cox 8 Table by Haven Medical

Ross Halls is joined by Stuart Watson to discuss the Ipswich Town 2025/26 retained list.The duo start with the news that Wes Burns is in negotiations with the club over a new deal, as is veteran third-choice keeper David Button.They also chat about the release of Conor Chaplin and Conor Townsend, before looking ahead to what the future holds for Harry Clarke and Cameron Humphreys, who have had their contract options exercised for a further 12 months.Then it's onto the returning loanees and a big summer ahead for the club.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Ross Halls caught up with former Ipswich Town forward Frank Nouble to discuss his time at Portman Road and journey in football in our Kings of Anglia podcast special.Frank spoke about a range of memories, including his early days in football, turning down a contract at Chelsea, playing in the Premier League with West Ham and joining Ipswich.He chats about his relationship with Mick McCarthy, his goals against Crystal Palace, meaning behind CLACK, and overall time in Suffolk.The duo also discuss his tag as a journeyman, playing in China and ambitions in coaching.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Ross Halls and Alex Jones are back with the latest episode of Ipswich Town Transfer Talk after a hectic week.The boys looks at links to experienced duo Nick Pope and Callum Wilson, assessing whether they are the right profiles to make the move to Portman Road this summer.Then it's onto some different names - Paris FC star Ilan Kebbal has is another reported target, while dubious rumours surrounding Henrik Falchener and Fisnik Asllani are mentioned as well.There's also some chat around left-field candidates to replace Kieran McKenna, who stepped down from his role as Blues boss earlier this week.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Episode: 3380 What underlies a term from physics: Ergodic (or Ergodicity).  Today, let us steal a word from physics.

Discover 5 key autoimmune triggers hiding in your past. From COVID and herpes simplex to staph, Epstein-Barr, and strep infections, Nurse Doza breaks down how past infections can reprogram your immune system to attack your own tissue — and what gut health has to do with it all. Gut (L-Glutamine) by MSW Nutrition Gut, featuring 4 grams of pure L-Glutamine per scoop, is the primary fuel source for the cells that line your intestinal wall. When past infections, antibiotics, or chronic stress compromise your gut barrier, your immune system loses its most important line of defense — creating the conditions where autoimmune triggers thrive. Gut helps repair the gut lining, reduce digestive inflammation, and support the immune cells that depend on a healthy gut to function properly. Whether you're managing an existing autoimmune disorder or working to prevent one, healing your gut is where it starts.

The current Ebola outbreak in the Democratic Republic of the Congo and neighboring Uganda is caused by the Bundibugyo virus. There's no specific treatment or vaccine for this strain, unlike the more common Zaire strain that caused the 2014 outbreak.  Molecular biologist Christian Happi has dedicated his career to improving genomic sequencing capabilities and virus monitoring across the continent of Africa. He joins Flora to discuss the challenges of the current outbreak and his vision for better disease surveillance.  Guest: Dr. Christian Happi is a distinguished professor at Redeemer's University and runs the Institute of Genomics and Global Health in Nigeria. Other episodes you may enjoy: Inside the Nebraska quarantine facility responding to hantavirus Can ‘Suggestion-Box Science' Make Public Health More Useful? Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that's keeping you up at night? Call us: 877-472-4374 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.